Skip to content

Clinical trials

Observational Fallopian Tube Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Phase: Observational Country / region: United States Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20041
20053
20062
20072
20081
20092
20103
20116
20121
20152
20163
20173
20182
20192
20203
20212
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated8
Unknown status5
Recruiting4
Active, not recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gynecologic Oncology Group8
M.D. Anderson Cancer Center4
Memorial Sloan Kettering Cancer Center4
National Cancer Institute (NCI)3
Precision Therapeutics3
Duke University2
University of Minnesota2
Abramson Cancer Center at Penn Medicine1
Boston Scientific Corporation1
George Washington University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms45
Ovarian Neoplasms42
Endometrial Neoplasms10
Carcinoma, Ovarian Epithelial9
Uterine Cervical Neoplasms9
Vulvar Neoplasms8
Breast Neoplasms6
Uterine Neoplasms6
Vaginal Neoplasms6
Lung Neoplasms5

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.